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Abstract
Alopecia X is a hair cycle arrest disorder in Pomeranians. Histologically, kenogen and telo-
gen hair follicles predominate, whereas anagen follicles are sparse. The induction of anagen
relies on the activation of hair follicle stem cells and their subsequent proliferation and differ-
entiation. Stem cell function depends on finely tuned interactions of signaling molecules and
transcription factors, which are not well defined in dogs. We performed transcriptome profil-
ing on skin biopsies to analyze altered molecular pathways in alopecia X. Biopsies from five
affected and four non-affected Pomeranians were investigated. Differential gene expression
revealed a downregulation of key regulator genes of the Wnt (CTNNB1, LEF1, TCF3,
WNT10B) and Shh (SHH, GLI1, SMO, PTCH2) pathways. In mice it has been shown that
Wnt and Shh signaling results in stem cell activation and differentiation Thus our findings
are in line with the lack of anagen hair follicles in dogs with Alopecia X. We also observed a
significant downregulation of the stem cell markers SOX9, LHX2, LGR5, TCF7L1 and GLI1
whereas NFATc1, a quiescence marker, was upregulated in alopecia X. Moreover, genes
coding for enzymes directly involved in the sex hormone metabolism (CYP1A1, CYP1B1,
HSD17B14) were differentially regulated in alopecia X. These findings are in agreement
with the so far proposed but not yet proven deregulation of the sex hormone metabolism in
this disease.
Introduction
Hair loss, hypotrichosis or alopecia in human beings and dogs is common and possible under-
lying causes are numerous. An intact hair coat is maintained by lifelong cycling of the hair fol-
licles (HFs) through periodic stages of growth (anagen), regression (catagen), and relative
quiescence (telogen) [1, 2]. A fourth cycle stage, during which the club hair is shed is known as
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exogen [3]. Kenogen is a term for HFs, which have passed the telogen stage, lost their hair fiber
(exogen) and remain empty for a certain time before a new anagen phase is initiated [4]. To
sustain this cyclic regeneration, each HF relies on its epithelial stem cells (SCs) which act as a
regeneration pool for the cells needed to maintain and remodel the epithelium of the continu-
ously cycling HF. The HF SC populations are characterized by different markers and reside in
niches that provide spatially distinct microenvironments for their maintenance and function
[5–7].
The coordination of the HC phases and the SC activity is dependent on complex interac-
tions between signals of the follicular (niche components) and dermal microenvironment (e.g.
fibroblasts, adipocytes, immune cells, nerve fibers), systemic factors (e.g. hormones, genetics,
age) and environmental factors (e.g. day light, nutrition, circadian rhythm) [8, 9]. In the
mouse the signaling crosstalk between SCs and their niche has been well characterized by now.
The state of the murine HF is mediated by a complex, delicately balanced interplay between
ligands, their receptors and transcription factors implicated in several mutually interacting sig-
naling pathways. These pathways include Sonic hedgehog (Shh), the wingless-type mouse
mammary tumor virus integration site (Wnt)/β-catenin, transforming growth factor (Tgf)-β,
fibroblast growth factor (Fgf), bone morphogenic protein (Bmp) and Notch signaling
(reviewed in [7, 10]). However, despite extensive research the complete understanding how
molecules of these pathways interact with each other and with other elements (e.g. pH) of the
SC niche, as well as with systemic and environmental factors is still not complete. In general it
can be noted that Bmp signals derived from dermal, adipose and epithelial tissue repress SC
activation and proliferation, while Wnt and Shh signals initiate and promote a new HC and
thus regenerate a new hair shaft.
Alopecia X (AX) is a non-inflammatory hair cycle disorder affecting most commonly Pom-
eranians. Different disease names were used for AX in the past, such as adult-onset hyposoma-
totropism, growth hormone-responsive alopecia, pseudo-Cushing’s disease, castration-
responsive alopecia, biopsy-responsive alopecia, adrenal hyperplasia-like syndrome, reflecting
the yet unknown pathomechanism of the disease (reviewed in [11–13]). The strong predisposi-
tion of the disease for breeds with a plush undercoat, pedigree analysis of affected dogs, and
the onset of the disease at a relatively young age suggest a hereditary background [14, 15]. Ini-
tially an adrenal steroid hormone imbalance similar to the congenital adrenal hyperplasia-like
syndrome, caused by a mutation in the CYP21A2 affecting the steroid 21-hydroxylase, in
humans was suggested as underlying cause [16, 17]. However, a genetic variant in this gene as
the cause for AX in dogs was excluded [18] and to date the mode of inheritance and the under-
lying pathomechanism of the impaired hair growth remain to be elucidated. Clinically the
dogs develop truncal alopecia and hyperpigmentation of the skin. Systemic illness is not associ-
ated with this disease [11, 16]. Histologically, kenogen and telogen hair follicles (HFs) predom-
inate, whereas anagen follicles are sparse [19].
The aims of the present study were 1) to identify differentially expressed genes and path-
ways in the skin of Pomeranians with AX as compared to healthy control Pomeranians by
transcriptome profiling and 2) to define genes which may be specifically involved in the patho-
genesis of AX.
Material and methods
Ethics statement
All biopsies were taken with informed owner consent after sedation and/or local anesthesia
with permission of the cantonal animal welfare committee, switzerland (permission number
BE31/13).
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Samples
Skin biopsies were taken from 5 Pomeranians with AX (2 intact males, 2 castrated males and 1
castrated female; dogs between 2 and 7 years of age) and 4 healthy control Pomeranians (2
intact males, 1 castrated male and 1 castrated female; dogs between 1 and 12 years of age). The
diagnosis was based on the clinical phenotype of the dogs, assessed by board certified veteri-
nary dermatologists and confirmed by the histological findings. Endocrinopathies were
excluded by the absence of systemic signs and appropriate laboratory tests.
From each dog with AX two 6mm punch biopsies from alopecic skin and from each control
dog two 6mm punch biopsies from haired skin were taken. Both biopsies were taken in close
vicinity to each other from the lateral caudal thorax in the control and alopecic dogs.
From each dog one biopsy was stored in RNAlater (76106; Qiagen; Hombrechtikon; Swit-
zerland) at -80˚C prior to RNA extraction. The other biopsy was fixed in 10% buffered forma-
lin, embedded in paraffin, cut as 4μm section and stained with hematoxylin and eosin prior to
the histological evaluation.
RNA extraction and cDNA sequencing
Prior to RNA extraction the skin biopsies were homogenized mechanically with the TissueR-
uptor device from Qiagen. Total RNA was extracted from the homogenized tissue using the
RNeasy Fibrous Tissue Mini Kit (74704; Qiagen; Hombrechtikon; Switzerland) according to
the manufacturer’s instructions. RNA quality was assessed with a Bioanalyzer (Agilent 2100;
Agilent Technologies). From each biopsy 1μg of high quality RNA (RNA integrity number:
RIN> 9) was used for stranded, paired-end cDNA library preparation (TruSeq RNA Library
Prep Kit v2, Illumina). Multiplexed total cDNA libraries were sequenced on one lane using the
Illumina HiSeq3000 with 2x150 bp paired-end sequencing cycles. Twenty million read pairs
per stranded library were collected on average. The Illumina BCL output files with base calls
and qualities were converted into FASTQ file format and demultiplexed. Data are available
from the European Nucleotide Archive and GenBank (accession no. PRJEB21761). All other
data are available in the paper and its Supporting Information files.
Mapping to reference genome
All reads that passed quality control were mapped to the dog genome reference (Can.Fam3.1)
by STAR aligner version 2.5.3a [20]. Reads were aligned using the following parameters: - -out-
FilterType BySJout - -outFilterMultimapNmax 50 - -alignSJoverhangMin 1 - -outFilterMis-
matchNmax 2 - -outFilterMismatchNoverLmax 0.04 - -alignIntronMin 20 - -alignIntronMax
1000000 - -alignMatesGapMax 1000000. The alignment of RNA-seq reads from each sample
was summarized by the number of uniquely mapped reads per sample including both single-
ton and both-ends mapped and number of splice alignments per sample. The read abundance
was calculated using HTseq and a NCBI transcript database (version 104) derived from the
CanFam3.1 dog genome assembly [21].
Differential expression
We used the DESeq2 package [22] to read the HTseq count data and filter for low/non-
expressed genes where the count is zero in all samples and a single count in one sample. The
count data were subjected to a regularized-logarithm transformation and a principal compo-
nent analysis (PCA) was performed to visualize the clustering of the case and control groups.
Following PCA analysis, we used DESeq2 v.1.6.3 to assess differential expression between
groups. DESeq2 applies a generalized linear model (GLM) to count data assuming a negative
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binomial distribution. For each gene, read counts were fit to a GLM with design model (~sex
+ condition) where condition was the factor of interest with two states: control and AX. Tran-
scripts were considered to be differentially expressed with a Benjamini and Hochberg false dis-
covery rate (FDR) of< 0.01.
Pathway analysis
The differentially expressed genes were mapped to biological networks using a manually
curated proprietary database (MetaCore™, GeneGo) and the MetaCore pathway analysis soft-
ware. For the enrichment analysis, the gene symbols of the differentially expressed proteins
were uploaded into the database, and the uploaded files were matched with known genes with
functional ontologies (GO) in MetaCore™ [23]. In addition the Panther Classification System
was used for the enrichment analysis [24].
Results
Differentially expressed genes
Fig 1 shows the clustering of samples based on their expression profiles. The PCA clusteriza-
tion successfully separates “Alopecia X” samples from “Control” ones and is not affected
by sex of the animals. Subsequently we applied the GLM model to identify differentially
expressed genes between “Alopecia X” and “Control”. We identified a total of 1598 differen-
tially expressed genes with a FDR of< 0.01. Of those, 569 genes were upregulated and 1029
were downregulated in dogs with AX (S1 Table).
Functional classification of differentially expressed genes
The enrichment analysis of the differentially expressed genes based on GO biological process
is depicted in Fig 2A. According to the GO categories, the majority of differentially regulated
genes could be categorized into cellular (45.8%) and metabolic (32.8%) processes. Within the
GO category cellular process, differentially regulated genes involved in cell communication
are overrepresented (Fig 2B).
The MetaCore pathway analysis software (GeneGo Inc.) was used to identify the GeneGo
Pathway Maps, Networks, and Processes. The analysis of both up-and downregulated genes
revealed that genes of the Wnt (p-value = 1.119e-7; S2 Table) and Shh (p-value = 8.456e-5; S3
Table) signaling pathways were significantly overrepresented.
Expression of hair cycle regulatory genes
We specifically analyzed genes of the Wnt, Shh, Bmp, Fgf and Tgf-β signaling pathways which
are also known to play a role in HF biology [10]. We identified a total of 47 differentially
expressed genes involved in one of these pathways (S4 Table).
The physiological role of some selected differentially regulated genes within the HC is
shown in Fig 3.
Expression of hair follicle stem cell markers
Next, we investigated the expression of genes coding for known HF SC markers [6, 7, 25–29]
and found differential expression of several SC and progenitor markers. Whereas SOX9,
LHX2, LGR5, TCF7L1 and GLI1 were downregulated, the transcription factor NFATc1, a HF
SC quiescent marker, was upregulated (S1 Table, Fig 3).
Gene deregulation in alopecia X
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Differentially expressed genes involved in steroidogenesis, melatonin
metabolism and in the vitamin D receptor pathway
In addition to the differentially regulated genes involved in known signaling pathways associ-
ated with the HC we identified 10 differentially regulated genes involved in the hypothalamic-
pituitary-gonadal axis including sex hormone synthesis, vitamin D synthesis and melatonin
metabolism (S5 Table, Fig 4).
Discussion
In our study we identified 47 differentially expressed genes in the alopecic skin of Pomeranians
with AX that are known play a role in murine HF physiology, suggesting that the canine HC is
controlled similar to mice. The majority of the differentially regulated genes codes for mole-
cules related to the Wnt- and Shh-pathways, which are the major players for anagen induction
and maintenance (reviewed in [30–34]). In our dataset we found a downregulation of genes
coding for the secreted Wnt proteins 10B and 5A (WNT10B,WNT5A) as well as for the Wnt
signaling receptors frizzled 3, 7, and 10 in dogs with AX. In addition our data indicate that
Wnt downstream signaling is impaired since genes coding for β-catenin (CTNNB1) and mem-
bers of the T cell factor/lymphoid enhancer factor family of transcription factors (LEF/TCF),
numerous other genes coding for important signaling molecules and transcription factors of
the Wnt signaling pathway (e.g. DLX3, CTNNB1,HOXC13, CUX1)) as well as Wnt target
genes (such as JAG1 and CDH3) are downregulated [35]. All of these molecules play a role in
the HC. Furthermore, also genes coding for Wnt agonists such as RSPO2 and agonist receptors
such as LGR4 and LGR5 are significantly downregulated. R-spondins are highly expressed in
mouse dermal papilla cells and are known to regulate HC progression by activating HF SCs in
altering the cell fate determination but not SC proliferation [36]. Downregulation of Wnt is
further supported by the upregulation of Wnt antagonists such as WIF1 and MMP7 [37, 38].
Furthermore, genes of the Shh pathway are downregulated, including SHH and SMO, its
receptor PTCH1, and the transcription factors GLI1 and GLI 3. It has been shown that Shh sig-
naling is involved in anagen initiation of both primary and secondary HFs and is expressed at
Fig 1. Principal component analysis of the samples in the first two component space. Samples are plotted across
the two most variable components (PC1 and PC2); sample clustering is rather based on condition and not sex.
https://doi.org/10.1371/journal.pone.0186469.g001
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high levels in the matrical cells of the HF bulb and thus is involved in the promotion of anagen
[39–41].
Bmp signaling has been shown to regulate the HC by inhibiting anagen induction [42, 43].
Thus, we expected an upregulation of Bmp signaling molecules in our dataset. However, unex-
pectedly we found a downregulation of BMP4, SMAD2 and SMAD7 all known to play a role in
SC quiescence [43]. Since at the same time NFATc1, a HF quiescence marker, occurring
upstream of Bmp signaling was upregulated and a downregulation of some Bmp antagonists
(e.g. BAMBI) is seen, we assume that the delicately balanced Bmp pathway, involving an inti-
mate interaction of many genes and cellular events is nevertheless differentially regulated thus
resulting in telogen arrest despite the downregulation of some BMP signaling molecules [44–
46].
The histological findings in skin biopsies from dogs with AX which clearly show an abun-
dance of telogen and kenogen HFs are in line with the transcriptome data suggesting an
impaired anagen induction and promotion [19].
Fig 2. Histogram and pie chart of the GO classification of differentially expressed genes using the
PANTHER Classification System. (A) The functional classification on the basis of the biological process
shows an overrepresentation of differentially regulated genes involved in cellular and metabolic processes.
(B) The majority of genes that are differentially regulated within the category of cellular process are involved in
cell communication, cell cycle and cellular component movement. The percentages in Figs 2A and 2B
correspond to the genes assigned to a specific GO term over the total number of differentially expressed
genes.
https://doi.org/10.1371/journal.pone.0186469.g002
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We could identify many follicular SC and progenitor markers in the canine transcriptome
of healthy dogs that were also reported in mice and humans [7, 25–28]. Importantly, some of
these were downregulated in dogs with AX (TCF7L1, LHX2, LGR5, GLI1 and SOX 9). A down-
regulation of HF SC markers has also been described in men with androgenic alopecia [47].
However, further investigations are warranted in men and dogs to elucidate, if the downregu-
lation of specific SC markers is specific for certain alopecic conditions or the consequence of
more general changes in diseased skin.
Besides the deregulation of genes playing a role in the HC and HF SC markers, our dataset
derived from skin biopsies reveals the deregulation of genes known to be relevant for the ste-
roid hormone metabolism.
An altered steroid hormone metabolism has been suggested by other authors as underlying
cause for AX but was never proven [12, 48–51]. This may partially be due to the fact that the
steroid hormone metabolism was assessed in the plasma of dogs and it is well known that
plasma hormonal concentrations vary substantially between individuals and within one indi-
vidual [51, 52]. Furthermore, there is increasing evidence that the skin itself has powerful neu-
roendocrine activities and hormones are produced and metabolized locally [53–56]. Thus,
measuring hormonal levels in the plasma may not be the appropriate method since a deregula-
tion directly in the skin may be causative for the disease. Since it has been shown, in various
studies that estrogen plays a major role in HF biology, specifically the inhibition of telogen-to-
anagen transition [57, 58] the hypothesis that an altered sex hormone metabolism plays a role
in the pathogenesis of AX deserves further investigations. Our dataset, derived from skin biop-
sies, supports the hypothesis that the sex hormone metabolism is locally deregulated in dogs
Fig 3. Differentially expressed genes in dogs with AX and their physiological function during specific
hair cycle phases. Black indicates downregulation and red indicates upregulation of the respective genes.
https://doi.org/10.1371/journal.pone.0186469.g003
Gene deregulation in alopecia X
PLOS ONE | https://doi.org/10.1371/journal.pone.0186469 October 24, 2017 7 / 14
with AX. We observed a significant downregulation of HSD17B14which codes for the 17β-
hydroxysteroid dehydrogenase14 (17β-HSD14) and an upregulation of the cytochrome P450
family members CYP1A1 and CYP1B1 as well as the downregulation of the estrogen receptor
(ESR)1. It has been shown that 17β-HSD14 is expressed in the skin and that it oxidizes estra-
diol into the less bioactive steroid metabolites estrone (Fig 4) [59]. The upregulation of
CYP1A1 and CYP1B1, involved in metabolizing estradiol and estrone to less bioactive metabo-
lites further supports the hypothesis that the estrogen metabolism is differentially regulated in
dogs with AX. In addition, the gene coding for ESR2 but not ESR1 is downregulated in our
data set. The affinity of ligands to ESRs differs. For example, the short-acting 17α-estradiol has
a higher affinity to ESR-α encoded by ESR1 whereas the biologically weak estriol has a higher
affinity to the ESR-β encoded by ESR2 [60]. Elevation of estriol concentrations as a conse-
quence of augmented estrone after downregulation of HSD17B14 could therefore explain the
downregulation of ESR2 and not ESR1 that we see in our dataset. The fact that ESR1 encoding
for ESR-α is not downregulated in our data set is also supported by a study in which the
Fig 4. Differentially expressed genes playing a role in sex hormone biosynthesis and metabolism.
Sex hormone biosynthesis and metabolism is accomplished by a complex cascade involving hormones and
enzymes of the hypothalamic-pituitary-gonadal axis, the vitamin D synthesis and the pineal gland hormone
melatonin. Since it has been shown that the skin has its own neuroendocrine system these complex
interactions may also occur in the skin. They are depicted in Fig 4. The differentially regulated genes involved
in this process are indicated in blue if they were downregulated and red if they were upregulated.
Abbreviations: DHEA, dehydroepiandrosterone; DHT, dehydrotestosterone; CYP, cytochrome P 450 family
enzymes; 5α-Red, 5α- Reductase; ESR, estrogen receptor; GnRH, gonadotropin- releasing hormone; FSH,
follicle- stimulation hormone; LH, luteinizing hormone; KISS1, kisspeptin 1 gene. In bold: endogenous female
sex hormones; their affinity for estrogen receptors is marked with * for higher affinity to ESR-α encoded by
ESR1 and ** for higher affinity to ESR-β encoded by ESR2. 1 indicates that melatonin decreases the levels of
these. # Calcitriol increases levels of estradiol.
https://doi.org/10.1371/journal.pone.0186469.g004
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estrogen receptor staining in the hair follicles was assessed in dogs with AX treated with mela-
tonin and hair regrowth was not associated with a change in staining intensity [49].
Another strong indication to support the hypothesis that the estrogen metabolism is differ-
entially regulated is that the vitamin D receptor gene (VDR) and the Retinoid X Receptor
Gamma gene (RXRG, whose protein forms heterodimers with VDR), as well as two members
of the vitamin D pathway (namely CYP27B1,CYP24A1) are significantly downregulated.
CYP27B1, encodes for an enzyme which activates Vitamin D3 and CYP24A1 is involved in
Vitamin D degradation (Fig 4). Furthermore Vitamin D has been shown to play an essential
role in the biosynthesis of estradiol in mice and pigs [61]. It is well known that keratinocytes
are the primary source of Vitamin D and its active metabolite is processed in the skin, support-
ing a local deregulation of the estrogen metabolism partially mediated by Vitamin D [62]. In
line with a differentially regulated estrogen metabolism is also the observed treatment response
of AX affected Pomeranians to melatonin [51]. The anti-estrogenic actions of melatonin are
extensively reviewed [63–68]. Since melatonin is also produced and metabolized in the skin it
can be assumed that CYP1A1 and CYP1B1, which are known to be involved in the degradation
of plasma melatonin, are also involved in the degradation of melatonin in the skin and treat-
ment of dogs with AX with melatonin at least partially compensates for this local degradation
[69–71]. Interesting in the context of a deregulated sex hormone metabolism is also the down-
regulation of the gene coding for kisspeptin (KISS1) in our data set. The downregulation of kis-
speptin is known to result in a lower GnRH release in the arcuate nucleus which in turn has via
hypothalamo–pituitary–adrenal axis an effect on the sex hormone metabolism [72]. It has
been shown that within the skin an own neuroendocrine system exists which functions similar
to the hypothalamo–pituitary–adrenal axis, catecholaminergic, cholinergic, steroidogenic and
secosteroidogenic systems [73–75]. Since we found a downregulation of kisspeptin in the skin
we can speculate that kisspeptin is also effective in the local endocrine metabolism. If this local
deregulation is the consequence of a systemic deregulation or occurs only in the skin warrants
further investigations. It has been reported that after the implantation of deslorelin, a GnRH
analogue hair was regrowing in 75% of the intact male Pomeranians with AX and there was an
60% overall positive response if neutered female Pomeranians with AX were included [50].
The positive effect of the treatment with a GnRH analogue supports that the GnRH expression
may be lower in dogs with AX. The fact that treatment with melatonin, which negatively regu-
lates GnRH secretion, resulted in hair regrowth in about 60% of the AX affected dogs, however
indicates that the regulatory mechanisms are more complex than known to date [51].
In summary, our results provide novel insights into the molecular factors that govern the
canine HC and their disruption in AX, which has not been shown before. They show that the
canine HC is regulated by similar signaling pathways as in mice. In addition, we show a dereg-
ulation of genes maintaining the SC compartment and the HC in AX dogs. If the downregula-
tion of some of the SC markers is specific for AX or is a consequence of alopecia in general
needs to be investigated by comparing our dataset with datasets from dogs with other non-
inflammatory alopecic disorders. Furthermore, our data strongly support the previously estab-
lished hypothesis that the steroid hormone metabolism is altered in Pomeranians with AX.
More specifically, there are indications that the estrogen metabolism is differentially regulated
in the skin.
Supporting information
S1 Table. Results of differential expression analysis. Significantly differentially expressed
genes with a false discovery rate (FDR) 0.01, sorted by log2 Fold Change; BaseMean, mean
of normalized read counts across all samples; LfcSE, standard error of the log2FoldChange;
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Stat, the log2FoldChange divided by lfcSE.
(XLSX)
S2 Table. Wnt-related genes. BaseMean, mean of normalized read counts across all samples;
Log2FC, log2 fold change; FDR, False discovery rate, refers to Benjamini-Hochberg adjusted
p- value.
(XLSX)
S3 Table. Shh-related genes. BaseMean, mean of normalized read counts across all samples;
Log2FC, log2 fold change; FDR, False discovery rate, refers to Benjamini-Hochberg adjusted
p- value.
(XLSX)
S4 Table. Differentially expressed genes known to be involved in the murine HC in alope-
cic skin from dogs with AX as compared to healthy Pomeranians. BaseMean, mean of nor-
malized read counts across all samples; Log2FC, log2 fold change; FDR, False discovery rate,
refers to Benjamini-Hochberg adjusted p- value.
(XLSX)
S5 Table. Differentially expressed genes involved in the regulation of gonadotropin releas-
ing hormone and sex hormone synthesis, vitamin D synthesis and melatonin metabolism.
BaseMean, mean of normalized read counts across all samples; Log2FC, log2 fold change;
FDR, False discovery rate, refers to Benjamini-Hochberg adjusted p- value; HF, hair follicle;
GnRH, Gonadotropin-releasing hormone; ORS, outer root sheath; DP, dermal papilla.
(XLSX)
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